GlassScriptPhysician profile
William B Bauman
NPI 1841295433
$1,737.64
in general payments reported to CMS, 2019-2025
11 companies · $206 in 2025
The $206 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $418 · 2021: $385 · 2022: $402 · 2023: $305 · 2024: $21.66 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $532.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $457.15 | 2019-2024 | Diamondback Coronary, Cardiomems |
| Shockwave Medical, INC | $298.52 | 2021-2022 | |
| Medtronic, INC. | $297.96 | 2021-2025 | Onyx Frontier |
| Abiomed | $268.99 | 2019-2023 | Impella |
| Medtronic Vascular, INC. | $107.78 | 2019 | |
| United Therapeutics Corporation | $98.04 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $97.23 | 2019 | |
| Terumo Medical Corporation | $62.50 | 2021 | |
| Amgen INC. | $27.00 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $16.73 | 2022 | |
| Cardiovascular Systems INC. | $5.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Bauman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.